021-51111890
购物车（0）
sales@molnova.cn
CBS-1114 HCl
CAS No. 33244-00-7
CBS-1114 HCl ( —— )
产品货号. M36143 CAS No. 33244-00-7
CBS-1114 HCl (N-Phenylbenzamidrazone hydrochloride) is a 5-lipoxygenase inhibitor and an anti-inflammatory compound in a good eye-permeable model.CBS-1114 HCl maintains and improves cardiac function, attenuates cardiac dysfunction, as well as reduces epicardial adipose tissue and/or pericardial adipose tissue in subjects with cardiovascular disease.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2519 | 有现货 |
|
| 5MG | ￥3472 | 有现货 |
|
| 10MG | ￥5136 | 有现货 |
|
| 25MG | ￥7718 | 有现货 |
|
| 50MG | ￥10635 | 有现货 |
|
| 100MG | ￥14000 | 有现货 |
|
| 500MG | ￥28152 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CBS-1114 HCl
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述CBS-1114 HCl (N-Phenylbenzamidrazone hydrochloride) is a 5-lipoxygenase inhibitor and an anti-inflammatory compound in a good eye-permeable model.CBS-1114 HCl maintains and improves cardiac function, attenuates cardiac dysfunction, as well as reduces epicardial adipose tissue and/or pericardial adipose tissue in subjects with cardiovascular disease.
-
产品描述CBS-1114 HCl (N-Phenylbenzamidrazone hydrochloride) is a 5-lipoxygenase inhibitor and an anti-inflammatory compound in a good eye-permeable model.CBS-1114 HCl maintains and improves cardiac function, attenuates cardiac dysfunction, as well as reduces epicardial adipose tissue and/or pericardial adipose tissue in subjects with cardiovascular disease.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Immunology/Inflammation
-
靶点Lipoxygenase
-
受体Lipoxygenase
-
研究领域——
-
适应症——
化学信息
-
CAS Number33244-00-7
-
分子量247.72
-
分子式C13H14ClN3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.N=C(NNC=1C=CC=CC1)C=2C=CC=CC2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Masoprocol
Masoprocol (meso-Nordihydroguaiaretic acid) 是一种有效且具有口服活性的脂氧合酶 (lipoxygenase) 抑制剂。Masoprocol 显示出抗高血糖活性。 Masoprocol 降低体内葡萄糖浓度和肝脏甘油三酯浓度。Masoprocol具有研究II型糖尿病的潜力。
-
Utreloxastat
Utreloxastat (PTC857) 是一种用于研究包括 α-突触核蛋白病、tau 蛋白病、ALS、创伤性脑损伤和缺血再灌注相关损伤在内的疾病的化合物。
-
Beta-boswellic acid
β-乳香酸及其衍生物（乳香素的主要成分）具有抗癌、抗肿瘤和抗高血脂活性。
